CN112295009A - Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof - Google Patents

Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof Download PDF

Info

Publication number
CN112295009A
CN112295009A CN202011137104.9A CN202011137104A CN112295009A CN 112295009 A CN112295009 A CN 112295009A CN 202011137104 A CN202011137104 A CN 202011137104A CN 112295009 A CN112295009 A CN 112295009A
Authority
CN
China
Prior art keywords
chondroitin sulfate
modified
stirring
parts
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202011137104.9A
Other languages
Chinese (zh)
Inventor
廖志星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011137104.9A priority Critical patent/CN112295009A/en
Publication of CN112295009A publication Critical patent/CN112295009A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D1/00Treatment of filament-forming or like material
    • D01D1/02Preparation of spinning solutions
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • D01D5/0092Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4382Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Textile Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Artificial Filaments (AREA)

Abstract

The invention belongs to the technical field of medical supplies, and particularly relates to a long-acting humidity-control antibacterial dressing and a preparation method and application thereof. Firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound; then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen; then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane; and finally, crosslinking the interior of the fibrous membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing. The dressing has good long-acting humidity control effect, and has excellent antibacterial performance and mechanical performance.

Description

Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof
Technical Field
The invention belongs to the technical field of medical supplies. More particularly, relates to a long-acting humidity-controlling antibacterial dressing and a preparation method and application thereof.
Background
Local wound and bleeding, infection and ulcer caused by the local wound are common injuries, the integrity of skin is damaged, the barrier capability of normally defending bacteria is lost, necrotic tissues of the wound and exudates containing a large amount of protein are good culture media for bacterial reproduction, and under the action of various factors, the wound is easy to generate local infection and even cause systemic infection, and finally the healing time is prolonged.
The dressing is a medical material which is widely applied clinically and used for covering wounds and the like. The traditional dressings mainly comprise natural gauze, synthetic fiber inner dressings, foaming polymer dressings, hydrocolloid dressings and the like. The traditional gauze dressing can not keep the wound surface moist, prevent the tissue cells from epithelization and delay the wound surface healing; dressing fibers are easy to fall off, foreign body reaction is caused, and healing is affected; the granulation tissue of the wound surface is easy to grow into meshes of the dressing to be adhered, and the new epithelium and granulation tissue are often damaged during dressing change to cause bleeding, so that the wound healing is not facilitated, and the pain of a patient is difficult to endure; the water absorption is not strong, the hemostatic effect is not good, and pathogens easily permeate gauze to infect wounds; the workload of dressing change is large. Overall, there are three challenges to be addressed in wound healing: constantly exuding tissue fluids, risk of bacterial infection and a slightly moist environment conducive to wound healing. Therefore, an ideal wound dressing should not only effectively absorb the tissue exudate, but also ensure the wound surface to have certain humidity, and have antibacterial property to prevent wound infection.
The hydrogel is a macromolecule with a three-dimensional space structure formed by cross-linking hydrophilic macromolecular compounds among molecules. Because of the peculiar hydrophilic structure of the hydrogel macromolecules, a large amount of water can be absorbed and retained in the hydrogel structure, and therefore, the hydrogel has good water absorption and retention properties. Compared with other dressings, the hydrogel dressing has unique advantages that the hydrogel dressing can prevent excessive loss of moisture and body fluid to achieve the effect of hemostasis; the antibacterial and anti-inflammatory fabric has good permeability to water and oxygen, can resist bacterial invasion to a certain extent and inhibit the growth of bacteria, and has the functions of antibiosis and antiphlogosis; the adhesive can be well attached to the wound surface, but cannot be adhered to the wound surface so as to avoid secondary injury caused by dressing replacement; the wound surface is in a moist environment without effusion, has good biocompatibility and can promote wound healing. But the composite material has the defect of poor mechanical property, is often fixed during application, causes inconvenience, has poor antibacterial property and cannot meet the requirement of clinical application.
Disclosure of Invention
The invention aims to solve the technical problem of overcoming the defects and defects of poor antibacterial performance and mechanical performance of the conventional hydrogel dressing and provides a long-acting humidity-controlling antibacterial dressing as well as a preparation method and application thereof.
The invention aims to provide a long-acting humidity-controlling antibacterial dressing.
The invention also aims to provide a preparation method of the long-acting humidity-control antibacterial dressing.
The invention also aims to provide application of the long-acting humidity-control antibacterial dressing as a medical dressing for skin wounds.
The above purpose of the invention is realized by the following technical scheme:
a preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing.
Preferably, in the step (1), the chondroitin sulfate is selected from any one or more of pig chondroitin sulfate, cow chondroitin sulfate, shark chondroitin sulfate, chicken chondroitin sulfate, duck chondroitin sulfate, cuttlefish chondroitin sulfate, sturgeon chondroitin sulfate, eel chondroitin sulfate, ray chondroitin sulfate and stingray chondroitin sulfate.
Preferably, in the step (1), the modified chondroitin sulfate is prepared by the following steps: adding 1 part of chondroitin sulfate into 5-8 parts of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 45-55 ℃, adding 1-1.2 parts of anhydride while stirring, keeping the temperature and stirring for 2-3 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
Further preferably, the acid anhydride is selected from any one of maleic anhydride, succinic anhydride or glutaric anhydride.
Preferably, in the step (1), the specific method for loading the nano zinc oxide is as follows: adding 1 part of modified chondroitin sulfate into 8-10 parts of methanol solution containing 0.01-0.02 mol/L zinc acetate, stirring and reacting for 2-3 hours at 40-50 ℃, then adding 8-10 parts of methanol solution containing 0.02-0.03 mol/L sodium hydroxide, stirring and reacting for 3-4 hours at 40-50 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
Preferably, the specific method of the step (2) comprises the following steps in parts by weight: adding 1 part of chondroitin sulfate compound into 8-10 parts of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 3-5 parts of natural collagen into the aqueous solution, stirring at 8-10 ℃ for 25-32 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
Further preferably, the natural collagen is selected from any one of porcine collagen and bovine collagen.
Preferably, the specific method of step (3) is as follows, in parts by weight: adding 1 part of modified collagen and 0.2-0.3 part of glycidol modified silk fibroin into 15-20 parts of deionized water, stirring for 30-35 hours at 8-10 ℃ to obtain spinning solution, and then performing electrostatic spinning to obtain the fiber membrane.
Further preferably, the process conditions of electrospinning are as follows: the positive voltage is 15-16 kV, the negative voltage is-0.1 to-0.15 kV, the flow rate of the spinning solution is 0.2-0.3 mm/min, and the receiving distance is 10-15 cm.
Preferably, in the step (3), the glycidyl modified silk fibroin is prepared by the following method in parts by weight: adding 1 part of silk fibroin, 0.1-0.2 part of glycidol and 0.1-0.2 part of sodium chloride into 8-10 parts of deionized water, stirring until the silk fibroin is completely dissolved, stirring at 60-65 ℃ for reaction for 2-3 hours, naturally cooling to room temperature (25 ℃), and soaking and washing with the deionized water for 2-4 days to remove unreacted substances, thus obtaining the glycidol modified silk fibroin.
Preferably, the specific method of the step (4) comprises the following steps in parts by weight: adding 1 part of procyanidine and 0.2-0.3 part of dialdehyde sodium carboxymethyl cellulose into 130-150 parts of deionized water, uniformly oscillating with ultrasonic waves, immersing 8-10 parts of fiber membrane in the deionized water, stirring at 8-10 ℃ for 5-8 hours, taking out, washing with deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
Further preferably, the preparation method of the dialdehyde sodium carboxymethyl cellulose refers to patent CN 104711702B.
The invention also aims to provide the long-acting humidity-controlling antibacterial dressing prepared by the preparation method.
The invention also aims to provide application of the long-acting humidity-control antibacterial dressing as a medical dressing for skin wounds.
The invention has the following beneficial effects:
firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound; then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen; then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane; and finally, crosslinking the interior of the fibrous membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing. The dressing has good long-acting humidity control effect, and has excellent antibacterial performance and mechanical performance.
Among them, chondroitin sulfate is an acidic mucopolysaccharide which contributes to improvement of blood circulation, acceleration of metabolism, promotion of absorption of a penetrant and elimination of inflammation, and has natural compatibility when applied to skin wounds. According to the invention, the modified chondroitin sulfate is obtained by modifying chondroitin sulfate with anhydride, and then the modified chondroitin sulfate is loaded with nano zinc oxide with an antibacterial effect, so that the antibacterial performance of the dressing is enhanced by the synergistic effect of the modified chondroitin sulfate and the nano zinc oxide. Moreover, the nano zinc oxide is coordinated and combined with carboxylic acid, so that the bonding stability is strong, and the mechanical property of the product is ensured. The chondroitin sulfate is characterized by extremely easy water absorption and strong water locking capability, and is also beneficial to ensuring the long-acting moisture control effect of the dressing.
The natural collagen has good biocompatibility but poor mechanical property, and the natural collagen and the glycidol modified silk fibroin are mixed to prepare spinning solution, and the spinning solution is prepared into a fiber membrane through electrostatic spinning, so that the mechanical property of the dressing is greatly improved. Meanwhile, the silk fibroin has a certain antibacterial property, and is interwoven with natural collagen to form a film, so that the antibacterial property of the dressing is improved.
According to the invention, procyanidine and dialdehyde sodium carboxymethyl cellulose are used as cross-linking agents, so that collagen and the like in a fibrous membrane are cross-linked, a three-dimensional network structure is favorably formed, the mechanical strength of the dressing is further improved, pores are enriched, and the long-acting humidity control performance and the antibacterial performance are further improved.
Detailed Description
The present invention is further illustrated by the following specific examples, which are not intended to limit the invention in any way. Reagents, methods and apparatus used in the present invention are conventional in the art unless otherwise indicated.
Unless otherwise indicated, reagents and materials used in the following examples are commercially available.
Example 1
A preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing.
In the step (1), the chondroitin sulfate is porcine chondroitin sulfate.
In the step (1), the preparation method of the modified chondroitin sulfate comprises the following steps: adding 1kg of chondroitin sulfate into 5kg of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 55 ℃, adding 1kg of anhydride while stirring, keeping the temperature and stirring for 3 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
The anhydride is maleic anhydride.
In the step (1), the specific method for loading the nano zinc oxide is as follows: adding 1kg of modified chondroitin sulfate into 8kg of methanol solution containing 0.02mol/L zinc acetate, stirring and reacting for 3 hours at 40 ℃, then adding 8kg of methanol solution containing 0.03mol/L sodium hydroxide, stirring and reacting for 4 hours at 40 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
The specific method of the step (2) is as follows: adding 1kg of chondroitin sulfate compound into 8kg of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 5kg of natural collagen into the aqueous solution, stirring at 8 ℃ for 32 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
The natural collagen is porcine collagen.
The specific method of the step (3) is as follows: adding 1kg of modified collagen and 0.2kg of glycidol modified silk fibroin into 20kg of deionized water, stirring for 35 hours at 8 ℃ to obtain spinning solution, and then carrying out electrostatic spinning to obtain the fiber membrane.
The process conditions of electrostatic spinning are as follows: the positive voltage is 15kV, the negative voltage is-0.15 kV, the flow rate of the spinning solution is 0.2mm/min, and the receiving distance is 15 cm.
In the step (3), the glycidol modified silk fibroin is prepared by the following method: adding 1kg of silk fibroin, 0.1kg of glycidol and 0.2kg of sodium chloride into 8kg of deionized water, stirring until the silk fibroin is completely dissolved, stirring and reacting for 2 hours at 65 ℃, naturally cooling to room temperature (25 ℃), and soaking and washing with the deionized water for 4 days to remove unreacted substances, thereby obtaining the glycidol modified silk fibroin.
The specific method of the step (4) is as follows: adding 1kg of procyanidine and 0.2kg of dialdehyde sodium carboxymethyl cellulose into 150kg of deionized water, uniformly oscillating by ultrasonic waves, immersing 8kg of fiber membrane in the deionized water, stirring for 5 hours at 10 ℃, taking out, washing by the deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
The preparation method of the dialdehyde sodium carboxymethyl cellulose comprises the following steps: pouring 2kg of sodium carboxymethylcellulose and 20L of acetic acid-sodium acetate buffer solution with the pH value of 5.0 into a reaction kettle at the same time, stirring at room temperature until the solution is clear, dissolving 0.5kg of sodium periodate in 4L of the buffer solution, slowly pouring the solution into the reaction kettle, stirring at the temperature of 25 ℃ for reaction for 72 hours, adding 0.1L of polyethylene glycol serving as a reaction terminator after the reaction is finished, slowly stirring for 1 hour, then adding 2kg of sodium chloride and 100L of acetone into the reaction kettle, standing to precipitate, removing a supernatant, and finally centrifuging, washing, dialyzing, and freeze-drying to obtain the dialdehyde sodium carboxymethylcellulose.
Example 2
A preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing.
In the step (1), the chondroitin sulfate is duck chondroitin sulfate.
In the step (1), the preparation method of the modified chondroitin sulfate comprises the following steps: adding 1kg of chondroitin sulfate into 8kg of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 45 ℃, adding 1.2kg of anhydride while stirring, keeping the temperature and stirring for 2 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
Further preferably, the acid anhydride is succinic anhydride.
In the step (1), the specific method for loading the nano zinc oxide is as follows: adding 1kg of modified chondroitin sulfate into 10kg of methanol solution containing 0.01mol/L zinc acetate, stirring and reacting for 2 hours at 50 ℃, then adding 10kg of methanol solution containing 0.02mol/L sodium hydroxide, stirring and reacting for 3 hours at 50 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
The specific method of the step (2) is as follows: adding 1kg of chondroitin sulfate compound into 10kg of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 3kg of natural collagen into the aqueous solution, stirring at 10 ℃ for 25 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
The natural collagen is bovine collagen.
The specific method of the step (3) is as follows: adding 1kg of modified collagen and 0.3kg of glycidol modified silk fibroin into 15kg of deionized water, stirring for 30 hours at 10 ℃ to obtain spinning solution, and then carrying out electrostatic spinning to obtain the fiber membrane.
The process conditions of electrostatic spinning are as follows: the positive voltage is 16kV, the negative voltage is-0.1 kV, the flow rate of the spinning solution is 0.3mm/min, and the receiving distance is 10 cm.
In the step (3), the glycidol modified silk fibroin is prepared by the following method: adding 1kg of silk fibroin, 0.2kg of glycidol and 0.1kg of sodium chloride into 10kg of deionized water, stirring until the silk fibroin is completely dissolved, stirring and reacting for 3 hours at 60 ℃, naturally cooling to room temperature (25 ℃), and soaking and washing with the deionized water for 2 days to remove unreacted substances, thus obtaining the glycidol modified silk fibroin.
The specific method of the step (4) is as follows: firstly, adding 1kg of procyanidine and 0.3kg of dialdehyde sodium carboxymethyl cellulose into 130kg of deionized water, carrying out ultrasonic oscillation uniformly, then immersing 10kg of fiber membrane into the mixture, stirring the mixture for 8 hours at the temperature of 8 ℃, taking the mixture out, washing the mixture with the deionized water, and carrying out disinfection and sterilization to obtain the long-acting humidity control antibacterial dressing.
The preparation method of the dialdehyde sodium carboxymethyl cellulose comprises the following steps: pouring 1kg of sodium carboxymethylcellulose and 50L of acetic acid-sodium acetate buffer solution with the pH value of 3.0 into a reaction kettle at the same time, stirring at room temperature until the solution is clear, dissolving 2kg of sodium periodate in 1L of the buffer solution, slowly pouring the solution into the reaction kettle, stirring at the temperature of 35 ℃ for reaction for 48 hours, adding 1L of polyethylene glycol serving as a reaction terminator after the reaction is finished, slowly stirring for 0.5 hour, then adding 5kg of sodium chloride and 30L of acetone into the reaction kettle, standing to precipitate, removing a supernatant, and finally centrifuging, washing, dialyzing, and freeze-drying to obtain the dialdehyde sodium carboxymethylcellulose.
Example 3
A preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing.
In the step (1), the chondroitin sulfate is ray chondroitin sulfate.
In the step (1), the preparation method of the modified chondroitin sulfate comprises the following steps: adding 1kg of chondroitin sulfate into 7kg of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 50 ℃, adding 1.1kg of anhydride while stirring, keeping the temperature and stirring for 2.5 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
Further preferably, the acid anhydride is glutaric anhydride.
In the step (1), the specific method for loading the nano zinc oxide is as follows: adding 1kg of modified chondroitin sulfate into 9kg of methanol solution containing 0.015mol/L zinc acetate, stirring and reacting for 2.5 hours at 45 ℃, then adding 9kg of methanol solution containing 0.025mol/L sodium hydroxide, stirring and reacting for 3.5 hours at 45 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
The specific method of the step (2) is as follows: adding 1kg of chondroitin sulfate compound into 9kg of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 4kg of natural collagen into the aqueous solution, stirring at 9 ℃ for 28 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
The natural collagen is porcine collagen.
The specific method of the step (3) is as follows: adding 1kg of modified collagen and 0.25kg of glycidol modified silk fibroin into 18kg of deionized water, stirring for 32 hours at 9 ℃ to obtain spinning solution, and then carrying out electrostatic spinning to obtain the fiber membrane.
The process conditions of electrostatic spinning are as follows: the positive voltage is 16kV, the negative voltage is-0.12 kV, the flow rate of the spinning solution is 0.25mm/min, and the receiving distance is 12 cm.
In the step (3), the glycidol modified silk fibroin is prepared by the following method: adding 1kg of silk fibroin, 0.15kg of glycidol and 0.15kg of sodium chloride into 9kg of deionized water, stirring until the silk fibroin, the glycidol and the sodium chloride are completely dissolved, stirring and reacting for 2.5 hours at 62 ℃, naturally cooling to room temperature (25 ℃), and soaking and washing with the deionized water for 3 days to remove unreacted substances, thus obtaining the glycidol modified silk fibroin.
The specific method of the step (4) is as follows: adding 1kg of procyanidine and 0.25kg of dialdehyde sodium carboxymethyl cellulose into 140kg of deionized water, uniformly oscillating by ultrasonic waves, immersing 9kg of fiber membrane into the mixture, stirring for 7 hours at 9 ℃, taking out, washing by the deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
The preparation method of the dialdehyde sodium carboxymethyl cellulose comprises the following steps: pouring 1.5kg of sodium carboxymethylcellulose and 40L of acetic acid-sodium acetate buffer solution with the pH value of 4.0 into a reaction kettle at the same time, stirring at room temperature until the solution is clear, dissolving 1kg of sodium periodate in 3L of the buffer solution, slowly pouring the solution into the reaction kettle, stirring at the temperature of 30 ℃ for reaction for 60 hours, adding 0.8L of polyethylene glycol serving as a reaction terminator after the reaction is finished, slowly stirring for 0.8 hour, adding 4kg of sodium chloride and 60L of acetone into the reaction kettle, standing to precipitate, removing a supernatant, and finally centrifuging, washing, dialyzing, and freeze-drying to obtain the dialdehyde sodium carboxymethylcellulose.
Comparative example 1
A preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, mixing natural collagen and glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(2) and then, under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose, crosslinking is carried out inside the fiber membrane to obtain the long-acting humidity-controlling antibacterial dressing.
The specific method of the step (1) is as follows: adding 1kg of natural collagen and 0.2kg of glycidol modified silk fibroin into 20kg of deionized water, stirring for 35 hours at 8 ℃ to obtain spinning solution, and then carrying out electrostatic spinning to obtain the fiber membrane.
The process conditions of electrostatic spinning are as follows: the positive voltage is 15kV, the negative voltage is-0.15 kV, the flow rate of the spinning solution is 0.2mm/min, and the receiving distance is 15 cm.
In the step (1), the glycidol modified silk fibroin is prepared by the following method: adding 1kg of silk fibroin, 0.1kg of glycidol and 0.2kg of sodium chloride into 8kg of deionized water, stirring until the silk fibroin is completely dissolved, stirring and reacting for 2 hours at 65 ℃, naturally cooling to room temperature (25 ℃), and soaking and washing with the deionized water for 4 days to remove unreacted substances, thereby obtaining the glycidol modified silk fibroin.
The specific method of the step (2) is as follows: adding 1kg of procyanidine and 0.2kg of dialdehyde sodium carboxymethyl cellulose into 150kg of deionized water, uniformly oscillating by ultrasonic waves, immersing 8kg of fiber membrane in the deionized water, stirring for 5 hours at 10 ℃, taking out, washing by the deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
The preparation method of the dialdehyde sodium carboxymethyl cellulose comprises the following steps: pouring 2kg of sodium carboxymethylcellulose and 20L of acetic acid-sodium acetate buffer solution with the pH value of 5.0 into a reaction kettle at the same time, stirring at room temperature until the solution is clear, dissolving 0.5kg of sodium periodate in 4L of the buffer solution, slowly pouring the solution into the reaction kettle, stirring at the temperature of 25 ℃ for reaction for 72 hours, adding 0.1L of polyethylene glycol serving as a reaction terminator after the reaction is finished, slowly stirring for 1 hour, then adding 2kg of sodium chloride and 100L of acetone into the reaction kettle, standing to precipitate, removing a supernatant, and finally centrifuging, washing, dialyzing, and freeze-drying to obtain the dialdehyde sodium carboxymethylcellulose.
Comparative example 2
A preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) preparing the modified collagen into spinning solution, and performing electrostatic spinning to obtain a fibrous membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing.
In the step (1), the chondroitin sulfate is porcine chondroitin sulfate.
In the step (1), the preparation method of the modified chondroitin sulfate comprises the following steps: adding 1kg of chondroitin sulfate into 5kg of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 55 ℃, adding 1kg of anhydride while stirring, keeping the temperature and stirring for 3 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
The anhydride is maleic anhydride.
In the step (1), the specific method for loading the nano zinc oxide is as follows: adding 1kg of modified chondroitin sulfate into 8kg of methanol solution containing 0.02mol/L zinc acetate, stirring and reacting for 3 hours at 40 ℃, then adding 8kg of methanol solution containing 0.03mol/L sodium hydroxide, stirring and reacting for 4 hours at 40 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
The specific method of the step (2) is as follows: adding 1kg of chondroitin sulfate compound into 8kg of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 5kg of natural collagen into the aqueous solution, stirring at 8 ℃ for 32 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
The natural collagen is porcine collagen.
The specific method of the step (3) is as follows: adding 1kg of modified collagen into 20kg of deionized water, stirring for 35 hours at 8 ℃ to obtain a spinning solution, and then carrying out electrostatic spinning to obtain the fiber membrane.
The process conditions of electrostatic spinning are as follows: the positive voltage is 15kV, the negative voltage is-0.15 kV, the flow rate of the spinning solution is 0.2mm/min, and the receiving distance is 15 cm.
The specific method of the step (4) is as follows: adding 1kg of procyanidine and 0.2kg of dialdehyde sodium carboxymethyl cellulose into 150kg of deionized water, uniformly oscillating by ultrasonic waves, immersing 8kg of fiber membrane in the deionized water, stirring for 5 hours at 10 ℃, taking out, washing by the deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
The preparation method of the dialdehyde sodium carboxymethyl cellulose comprises the following steps: pouring 2kg of sodium carboxymethylcellulose and 20L of acetic acid-sodium acetate buffer solution with the pH value of 5.0 into a reaction kettle at the same time, stirring at room temperature until the solution is clear, dissolving 0.5kg of sodium periodate in 4L of the buffer solution, slowly pouring the solution into the reaction kettle, stirring at the temperature of 25 ℃ for reaction for 72 hours, adding 0.1L of polyethylene glycol serving as a reaction terminator after the reaction is finished, slowly stirring for 1 hour, then adding 2kg of sodium chloride and 100L of acetone into the reaction kettle, standing to precipitate, removing a supernatant, and finally centrifuging, washing, dialyzing, and freeze-drying to obtain the dialdehyde sodium carboxymethylcellulose.
Comparative example 3
A preparation method of a long-acting humidity-control antibacterial dressing comprises the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine to obtain the long-acting humidity-controlling antibacterial dressing.
In the step (1), the chondroitin sulfate is porcine chondroitin sulfate.
In the step (1), the preparation method of the modified chondroitin sulfate comprises the following steps: adding 1kg of chondroitin sulfate into 5kg of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 55 ℃, adding 1kg of anhydride while stirring, keeping the temperature and stirring for 3 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
The anhydride is maleic anhydride.
In the step (1), the specific method for loading the nano zinc oxide is as follows: adding 1kg of modified chondroitin sulfate into 8kg of methanol solution containing 0.02mol/L zinc acetate, stirring and reacting for 3 hours at 40 ℃, then adding 8kg of methanol solution containing 0.03mol/L sodium hydroxide, stirring and reacting for 4 hours at 40 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
The specific method of the step (2) is as follows: adding 1kg of chondroitin sulfate compound into 8kg of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 5kg of natural collagen into the aqueous solution, stirring at 8 ℃ for 32 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
The natural collagen is porcine collagen.
The specific method of the step (3) is as follows: adding 1kg of modified collagen and 0.2kg of glycidol modified silk fibroin into 20kg of deionized water, stirring for 35 hours at 8 ℃ to obtain spinning solution, and then carrying out electrostatic spinning to obtain the fiber membrane.
The process conditions of electrostatic spinning are as follows: the positive voltage is 15kV, the negative voltage is-0.15 kV, the flow rate of the spinning solution is 0.2mm/min, and the receiving distance is 15 cm.
In the step (3), the glycidol modified silk fibroin is prepared by the following method: adding 1kg of silk fibroin, 0.1kg of glycidol and 0.2kg of sodium chloride into 8kg of deionized water, stirring until the silk fibroin is completely dissolved, stirring and reacting for 2 hours at 65 ℃, naturally cooling to room temperature (25 ℃), and soaking and washing with the deionized water for 4 days to remove unreacted substances, thereby obtaining the glycidol modified silk fibroin.
The specific method of the step (4) is as follows: adding 1kg of procyanidine into 150kg of deionized water, uniformly oscillating by ultrasonic waves, immersing 8kg of fiber membrane in the deionized water, stirring for 5 hours at 10 ℃, taking out, washing by the deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
Test examples
1. The humidity control effect is as follows:
and (3) testing conditions are as follows: at 37 ℃, the swelling degree is (Wt-Wo)/Wo, where Wt is the weight of the dressing at which swelling equilibrium is reached and Wo is the weight of the dried dressing. The moisture control effect of the dressings obtained in examples 1-3 and comparative examples 1-3 was examined with reference to the swelling and drug release performance of NIPAAm-based copolymerized temperature-sensitive gel (Panchun, Shi, Longqingde, et al, school of the university of south and China (Nature science edition), 2007, 38 (5): 906-911), and the results are shown in Table 1.
TABLE 1 moisture control Effect examination
Figure BDA0002737079490000121
As can be seen from Table 1, the dressings obtained in examples 1 to 3 can achieve the swelling equilibrium in a short period of time, have a high degree of swelling, and have a long retention time of the swelling equilibrium.
Comparative example 1 step (1) was omitted, and the natural collagen was not modified with chondroitin sulfate complex, and the moisture control performance of the obtained dressing was significantly deteriorated; comparative example 2 in step (3), glycidol modified silk fibroin is omitted, cross-linking synergy between proteins is lacked, and the moisture control performance of the dressing is obviously deteriorated; in the comparative example 3, the dialdehyde sodium carboxymethyl cellulose is omitted in the step (4), and the protein crosslinking is insufficient only by the crosslinking action of the procyanidin, so that the humidity control performance of the product is influenced.
2. Mechanical properties:
the tensile strength of the dressings obtained in examples 1 to 3 and comparative examples 1 to 3 was measured by an extensional rheometer, and the results are shown in Table 2.
A tensile strength σ t ═ p/(b × d), where σ t is a tensile strength (MPa); p is the maximum load (N); b is the specimen width (mm); d is the specimen thickness (mm).
TABLE 2 tensile Strength comparison
Sample (I) Tensile Strength (MPa)
Example 1 8.22
Example 2 8.28
Example 3 8.34
Comparative example 1 6.11
Comparative example 2 4.56
Comparative example 3 5.24
As is clear from Table 2, the dressings obtained in examples 1 to 3 had high tensile strength and excellent mechanical properties.
Comparative example 1 step (1) was omitted, and the chondroitin sulfate complex was not added to modify the native collagen, and the mechanical properties and the like of the obtained dressing were significantly deteriorated; in the comparative example 2, the glycidol modified silk fibroin is omitted in the step (3), the cross-linking synergy among the proteins is lacked, and the mechanical properties and the like of the dressing are obviously poor; in the comparative example 3, the dialdehyde sodium carboxymethyl cellulose is omitted in the step (4), and the protein crosslinking is insufficient only by the crosslinking action of the procyanidin, so that the mechanical properties of the product are influenced.
3. Antibacterial property:
evaluation of textile antibacterial properties according to GB/T20944.3-2008, part 3: the antibacterial performance of the dressing of the invention is measured by a vibration bottle method. The strains are Candida albicans and Escherichia coli, and the concentration of the bacteria liquid is 105~107cfu/mL. Firstly, adding buffered normal saline and a dressing product into a triangular flask, sterilizing for 20min in 0.1MPa steam at 121 ℃ and cooling to room temperature, transferring 1mL of bacterial liquid by using a 1mL sterile graduated pipette, and adding the bacterial liquid into the triangular flask. To force the sample into contact with the bacteria, the shaker was shaken for several hours at 37 ℃. 0.1mL of the solution before and after shaking was applied to nutrient agar medium, incubated at 37 ℃ for 24 hours, and compared, the results are shown in Table 3.
TABLE 3 comparison of antibacterial Properties
Sample (I) Candida albicans inhibitory rate (%) Escherichia coli inhibitory rate (%)
Example 1 ≥99.9 ≥99.9
Example 2 ≥99.9 ≥99.9
Example 3 ≥99.9 ≥99.9
Comparative example 1 94.8 95.1
Comparative example 2 93.2 93.8
Comparative example 3 96.2 97.1
As can be seen from Table 3, the dressings obtained in examples 1 to 3 have a high bacteriostatic rate against Candida albicans and Escherichia coli.
Comparative example 1 step (1) was omitted, and the natural collagen was not modified with chondroitin sulfate complex, and the antibacterial property of the obtained dressing was significantly deteriorated; in the comparative example 2, the glycidol modified silk fibroin is omitted in the step (3), the cross-linking synergy among the proteins is lacked, and the antibacterial performance of the dressing is obviously poor; in the comparative example 3, the dialdehyde sodium carboxymethyl cellulose is omitted in the step (4), and the protein crosslinking is insufficient only by the crosslinking action of the procyanidin, so that the antibacterial performance of the product is influenced.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.

Claims (10)

1. A preparation method of a long-acting humidity-control antibacterial dressing is characterized by comprising the following specific steps:
(1) firstly, modifying chondroitin sulfate by using anhydride to obtain modified chondroitin sulfate, and then loading nano zinc oxide on the modified chondroitin sulfate to obtain a chondroitin sulfate compound;
(2) then adding the natural collagen into the aqueous solution containing the chondroitin sulfate compound, and carrying out modification treatment to obtain modified collagen;
(3) then mixing the modified collagen and the glycidol modified silk fibroin to prepare spinning solution, and performing electrostatic spinning to obtain a fiber membrane;
(4) and finally, crosslinking the interior of the fiber membrane under the crosslinking action of procyanidine and dialdehyde sodium carboxymethyl cellulose to obtain the long-acting humidity-controlling antibacterial dressing.
2. The method according to claim 1, wherein in the step (1), the modified chondroitin sulfate is prepared by the following method in parts by weight: adding 1 part of chondroitin sulfate into 5-8 parts of water, stirring until the chondroitin sulfate is completely dissolved, then stirring and heating to 45-55 ℃, adding 1-1.2 parts of anhydride while stirring, keeping the temperature and stirring for 2-3 hours, and carrying out vacuum freeze drying to obtain the modified chondroitin sulfate.
3. The method according to claim 2, wherein the acid anhydride is selected from any one of maleic anhydride, succinic anhydride, and glutaric anhydride.
4. The preparation method according to claim 1, wherein in the step (1), the specific method for loading the nano zinc oxide is as follows in parts by weight: adding 1 part of modified chondroitin sulfate into 8-10 parts of methanol solution containing 0.01-0.02 mol/L zinc acetate, stirring and reacting for 2-3 hours at 40-50 ℃, then adding 8-10 parts of methanol solution containing 0.02-0.03 mol/L sodium hydroxide, stirring and reacting for 3-4 hours at 40-50 ℃, and carrying out vacuum freeze drying to obtain the chondroitin sulfate compound.
5. The preparation method according to claim 1, wherein the specific method of the step (2) comprises the following steps in parts by weight: adding 1 part of chondroitin sulfate compound into 8-10 parts of acetic acid-sodium acetate buffer solution with the pH value of 4, uniformly oscillating by ultrasonic waves to obtain an aqueous solution, adding 3-5 parts of natural collagen into the aqueous solution, stirring at 8-10 ℃ for 25-32 hours, and carrying out vacuum freeze drying to obtain the modified collagen.
6. The preparation method according to claim 1, wherein the specific method of step (3) is as follows, in parts by weight: adding 1 part of modified collagen and 0.2-0.3 part of glycidol modified silk fibroin into 15-20 parts of deionized water, stirring for 30-35 hours at 8-10 ℃ to obtain spinning solution, and then performing electrostatic spinning to obtain the fiber membrane.
7. The preparation method of claim 1, wherein in the step (3), the glycidyl modified silk fibroin is prepared by the following method in parts by weight: adding 1 part of silk fibroin, 0.1-0.2 part of glycidol and 0.1-0.2 part of sodium chloride into 8-10 parts of deionized water, stirring until the silk fibroin is completely dissolved, stirring at 60-65 ℃ for reaction for 2-3 hours, naturally cooling to room temperature, and soaking and washing with deionized water for 2-4 days to remove unreacted substances, thus obtaining the glycidol modified silk fibroin.
8. The preparation method according to claim 1, wherein the specific method of the step (4) comprises the following steps in parts by weight: adding 1 part of procyanidine and 0.2-0.3 part of dialdehyde sodium carboxymethyl cellulose into 130-150 parts of deionized water, uniformly oscillating with ultrasonic waves, immersing 8-10 parts of fiber membrane in the deionized water, stirring at 8-10 ℃ for 5-8 hours, taking out, washing with deionized water, and sterilizing to obtain the long-acting humidity-controlling antibacterial dressing.
9. A long-acting humidity-controlling antibacterial dressing obtained by the preparation method of any one of claims 1-8.
10. Use of a long-acting moisture-controlling antimicrobial dressing according to claim 9 as a medical dressing for skin wounds.
CN202011137104.9A 2020-10-22 2020-10-22 Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof Withdrawn CN112295009A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011137104.9A CN112295009A (en) 2020-10-22 2020-10-22 Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011137104.9A CN112295009A (en) 2020-10-22 2020-10-22 Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN112295009A true CN112295009A (en) 2021-02-02

Family

ID=74328425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011137104.9A Withdrawn CN112295009A (en) 2020-10-22 2020-10-22 Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN112295009A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601956A (en) * 2022-03-15 2022-06-10 湖北省妇幼保健院 Medical hemostatic dressing and preparation method thereof
CN117357467A (en) * 2023-10-26 2024-01-09 广东茂名健康职业学院 Traditional Chinese medicine gel for relieving skin inflammation and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601956A (en) * 2022-03-15 2022-06-10 湖北省妇幼保健院 Medical hemostatic dressing and preparation method thereof
CN114601956B (en) * 2022-03-15 2022-10-21 湖北省妇幼保健院 Medical hemostatic dressing and preparation method thereof
CN117357467A (en) * 2023-10-26 2024-01-09 广东茂名健康职业学院 Traditional Chinese medicine gel for relieving skin inflammation and preparation method thereof
CN117357467B (en) * 2023-10-26 2024-04-26 广东茂名健康职业学院 Traditional Chinese medicine gel for relieving skin inflammation and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104069537B (en) Sodium alginate-sodium carboxymethyl cellulose-Chitosan in Wound Dressing and preparation method thereof
CN112300420B (en) Injectable antibacterial interpenetrating double-network hydrogel and preparation method and application thereof
CN111154149A (en) Hydrogel and preparation method and dressing thereof
CN111228040A (en) Absorbable anti-adhesion dressing and preparation method thereof
CN112295009A (en) Long-acting humidity-controlling antibacterial dressing and preparation method and application thereof
CN110876815A (en) Hydrogel loaded with platelet-rich plasma and antibacterial peptide, and preparation method and application thereof
CN113289050B (en) Hemostatic sponge and preparation method thereof
CN111053947A (en) Konjac glucomannan/fish gelatin hydrogel as well as preparation method and application thereof
CN111166931A (en) Methacrylic acid sericin/chitosan quaternary ammonium salt hydrogel and preparation method and application thereof
CN111973800A (en) Drug-loaded slow-release hydrogel and preparation method and application thereof
CN107823699B (en) Hemostatic anti-adhesion membrane and preparation method thereof
CN111690078B (en) Double-quaternized chitosan derivative, synthetic method thereof, composite sponge biological dressing containing double quaternized chitosan derivative and application of composite sponge biological dressing
CN108245700A (en) A kind of hydroxypropyl methyl cellulose chitosan film dressing and preparation method thereof
CN106822980B (en) Plasticized nano bacterial cellulose functional dressing and preparation method thereof
CN110917391A (en) Polypeptide modified sodium alginate/PVA hydrogel dressing and preparation method thereof
CN112807483B (en) Anti-inflammatory, antibacterial and hemostatic double-network hydrogel and preparation method and application thereof
CN113750285A (en) Composite aerogel dressing and preparation method thereof
CN113509591A (en) Antibacterial cationic injectable hydrogel dressing and preparation method thereof
CN112870429A (en) Chitosan-based polyelectrolyte composite hemostatic sponge, preparation method and application
CN108815562A (en) A kind of preparation method of compound hemostatic material
CN110448714B (en) Moisture-absorbing and bacteriostatic chitosan/sodium alginate interwoven dressing and preparation method thereof
CN112007201A (en) Adhesive antibacterial hemostatic sponge and preparation method thereof
CN114225113B (en) Degradable artificial dura mater with double-layer structure and preparation method thereof
CN112472867A (en) Antibacterial medical hydrogel dressing and preparation method thereof
CN113980326A (en) High-antibacterial-property chitosan-silver composite sponge and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20210202